Mouse Anti-Mouse BKBeta2 potassium channel Monoclonal Antibody, Unconjugated, Clone N53/32 from UC Davis/NINDS/NIMH NeuroMab Facility
... inhibitor (IC50 = 59.2 M). Formula: C 29 H... RT CAS: 33419-42-0 Solubility: Soluble ...aalpha,9beta(R*)]]-9-[(4,6-O-Ethylidene-beta-D-glu...3,5-dimethoxyphenyl)-furo[3',4':6,7]naphtho[2,3-d]...
Rabbit Anti-Human ALS2CR2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-IKKbeta / IKK-2 Polyclonal Antibody, Unconjugated from BioVision
Biology Products:(Date:11/26/2009)...nd. - A new generation of ultrasmall transistors a...res called semiconducting nanowires are closer to ...M, Purdue University and the University of Califor...ed how to create nanowires with layers of differen... level, which is a critical requirement for making...
(Date:11/25/2009)...TON,Fla.,Nov.25/PRNewswire/--Formanybusinesses,200...,slargestandfastestgrowingnetworkofexpertphysician...denticalhormones has grownthenumberof physicians...ans -andisinprogresstoaddmorephysician-ownedcenter..., Inthepastyear ,BodyLogicMDhasopened13newbioiden...
(Date:11/25/2009)... Nov. 25 Ardea Bioscienc...ry D. Quart, Pharm.D., president and chief executi... Annual Health Care Conference. , ,Presentation d...Health Care Conference,Date: Tuesday, Decembe...on: The New York Palace Hotel, New York, NY,Webca...
(Date:11/24/2009)... The New York investment bank KTA Capital,s clie... an AU$6.7 mil convertible note private placement ...acement was arranged by KTA Capital as Neuren,s ex... New York (PRWEB) November 23, 2009 -...ital, LLC ("KTA Capital") has announced ...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2